Physicians' Academy for Cardiovascular Education

New insights and guidelines for the management of CKD and diabetes

10' education - May 31, 2022 - Prof. Johannes Mann, MD - Munich, Germany

Video navigation menu

  • Three gigantic risk in DKD; What helps? 0:35
  • KDIGO guidelines for treatment of patients with T2DM and CKD 3:09
  • Evidence supporting role of GLP-1RA for kidney benefit 4:49
  • Recent trial data with exendin-based GLP-1RA 7:47

Transcript

Show transcript

Educational information

This lecture by Johannes Mann was part of the EBAC-accredited symposium "Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RA" held during the ERA 2022 congress.

Faculty

Johannes Mann is professor of medicine at the University of Erlangen-Nürnberg, and affiliated at the KfH Kidney Center, Munich, Germany

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk A/S.

Click here for the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: